NEW YORK, March 03, 2023 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the schedule of data presentations highlighting data...
Management to provide an update on its regulatory and partnering strategy for the United States and EuropeCHARLOTTESVILLE, Va., March 02,...
Conference Call and Webcast Scheduled for Thursday, March 16 at 8:30 am Eastern TimeYAVNE, Israel, March 02, 2023 (GLOBE NEWSWIRE)...
REDWOOD CITY, Calif., March 02, 2023 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a biopharmaceutical company focused on...
CAMBRIDGE, Mass., March 02, 2023 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular...
AJ201 is being evaluated in a Phase 1b/2a clinical trial in the U.S. for the rare X-linked genetic neurodegenerative disease...
VANCOUVER, British Columbia, March 02, 2023 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) (the “Company” or...
ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MARCH 2023 at 15.00 EET Orion Corporation: Managers’ transactions – Jari Karlson Orion Corporation...
ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MARCH 2023 at 15.00 EET Orion Corporation: Managers’ transactions – Olli Huotari Orion Corporation...
ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MARCH 2023 at 15.00 EET Orion Corporation: Managers’ transactions – Satu Ahomäki Orion Corporation...
ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MARCH 2023 at 15.00 EET Orion Corporation: Managers’ transactions – Juhani Kankaanpää Orion Corporation...
ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MARCH 2023 at 15.00 EET Orion Corporation: Managers’ transactions – Virve Laitinen Orion Corporation...
ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MARCH 2023 at 15.00 EET Orion Corporation: Managers’ transactions – Niclas Lindstedt Orion Corporation...
ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MARCH 2023 at 15.00 EET Orion Corporation: Managers’ transactions – Hao Pan Orion Corporation...
ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MARCH 2023 at 15.00 EET Orion Corporation: Managers’ transactions – Outi Vaarala Orion Corporation...
WALTHAM, Mass., March 02, 2023 (GLOBE NEWSWIRE) -- Aerovate Therapeutics, Inc. (Nasdaq: AVTE), a clinical stage biopharmaceutical company focused on...
SOUTH SAN FRANCISCO, Calif., March 01, 2023 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. (NGM Bio) (Nasdaq: NGM), a biotechnology company...
New evidence-based reports offer timely analysis and actionable guidance to drug developers bringing critical new therapies to marketDURHAM, N.C., Feb. 28,...
FREMONT, CA, Feb. 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical...
Hashad is a former executive at Avanir, Amgen, Boehringer Ingelheim, Eli Lilly, and early-stage biotechnology companies Global leader brings over...